The Ozempic lawsuit landscape has been evolving rapidly in 2025. This article dives into the latest updates surrounding legal actions against Ozempic, a popular weight-loss and diabetes drug.
We’ll explore the reasons behind these lawsuits, recent developments, and what they mean for users in simple, easy-to-understand language.
What Is Ozempic and Why Are Lawsuits Happening?
Ozempic is a medication containing semaglutide, used to manage Type 2 diabetes and aid weight loss. It’s part of a class of drugs called GLP-1 receptor agonists.
While effective, some users have reported severe side effects, sparking legal action. These lawsuits claim that the drug’s manufacturer, Novo Nordisk, didn’t properly warn users about serious risks.
Patients have reported side effects like gastroparesis (stomach paralysis), vision loss, and bowel obstructions. Some lawsuits even allege fatal outcomes linked to these complications.
The core issue is whether Novo Nordisk failed to disclose these risks adequately. This has led to a growing number of legal claims across the United States.
Key Side Effects Driving the Lawsuits
The Ozempic lawsuits focus on several serious health issues. These side effects have been reported by patients who used Ozempic or similar drugs like Wegovy and Rybelsus. Here’s a look at the main concerns:
- Gastroparesis: A condition where the stomach cannot empty properly, causing nausea, vomiting, and pain.
- Vision Loss (NAION): Non-arteritic anterior ischemic optic neuropathy, a rare condition leading to sudden vision loss.
- Bowel Obstruction: Blockages in the intestines, which can be life-threatening.
- Gallbladder Issues: Including gallstones and gallbladder removal due to complications.
- Pancreatitis: Inflammation of the pancreas, which can be severe in some cases.
These side effects have led to significant health challenges for some users. Many claim they weren’t warned about these risks before starting the medication.
The Multidistrict Litigation (MDL) Explained
Many Ozempic lawsuits have been consolidated into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania. As of August 2024, over 100 lawsuits were part of this MDL, officially named “In Re Glucagon-like Peptide-1 Receptor Agonists Products Liability Litigation, MDL No. 3094.” This process helps manage similar cases efficiently.
The MDL focuses on severe gastrointestinal injuries, like gastroparesis and bowel obstruction. However, vision loss cases, particularly those involving NAION, are being handled separately.
The MDL is still in pretrial proceedings, examining whether these drugs cause the alleged injuries. No large-scale settlements are expected soon, as the process could take years.
Recent Developments in Ozempic Lawsuits
The Ozempic lawsuit latest news highlights several key updates in 2025. Legal actions are increasing, with more patients coming forward. Here are some recent developments:
- Vision Loss Claims: A Maryland man, Todd Engel, filed a lawsuit in April 2025, claiming Ozempic caused his blindness due to NAION. Similar lawsuits have emerged in New York and New Jersey.
- Federal Judge Ruling: In June 2025, a Texas judge upheld the FDA’s decision to remove semaglutide from the drug shortage list. This rejected compounding pharmacies’ attempts to continue making Ozempic copies.
- Research Findings: Studies from Harvard and Denmark suggest a link between semaglutide and NAION. However, Novo Nordisk denies that vision loss is a known side effect.
These updates show the complexity of the legal battle. Patients and lawyers continue to push for accountability from Novo Nordisk.
Who Can File an Ozempic Lawsuit?
Not everyone who used Ozempic can file a lawsuit. Eligibility depends on specific criteria. Here’s what typically qualifies someone to join the litigation:
- Severe Side Effects: You must have experienced serious complications like gastroparesis, vision loss, or bowel obstruction after taking Ozempic.
- Medical Documentation: Proof of your diagnosis and its connection to Ozempic use is crucial.
- Timely Filing: Most states have a statute of limitations, meaning you must file within a certain time frame after your injury.
If you believe you qualify, consulting an attorney is a good first step. Many law firms offer free consultations to evaluate your case.
What Compensation Are Plaintiffs Seeking?
Plaintiffs in Ozempic lawsuits are seeking various forms of compensation. These aim to cover the damages caused by the drug’s side effects. Common claims include:
- Medical expenses for treating complications.
- Lost wages due to inability to work.
- Pain and suffering from physical and emotional distress.
- Punitive damages if negligence is proven.
In cases of death, families may file wrongful death lawsuits. Compensation amounts vary, and no major settlements have been reported yet.
Table: Key Ozempic Lawsuit Statistics (As of June 2025)
| Category | Details |
|---|---|
| Number of MDL Lawsuits | Over 105 (as of August 2024) |
| Primary Side Effects | Gastroparesis, vision loss (NAION), bowel obstruction, gallbladder issues |
| MDL Location | Eastern District of Pennsylvania |
| Key Manufacturer | Novo Nordisk |
| Expected Settlement Timeline | Likely years away, as pretrial proceedings continue |
This table summarizes the scale and focus of the ongoing litigation. It’s a snapshot of where things stand in mid-2025.
Novo Nordisk’s Response to the Lawsuits
Novo Nordisk, the maker of Ozempic, has defended its medications. The company argues that the benefits of semaglutide outweigh the risks for most patients. They also state that vision loss, like NAION, is not a recognized side effect based on current data.
Novo Nordisk has faced legal challenges before. In 2023, they were sued alongside Eli Lilly (maker of Mounjaro) for gastrointestinal side effects.
The company is also actively fighting against compounding pharmacies selling unauthorized semaglutide copies, with over 100 lawsuits filed across 32 states.
Public and Media Attention
The Ozempic lawsuit latest news has drawn significant media coverage. Outlets like CBS News and Reuters have reported on the growing number of claims. Public interest is high, especially as celebrities like Amanda Bynes and Lizzo have discussed using Ozempic for weight loss.
Social media platforms, including X, show mixed sentiments. Some users praise Ozempic for its weight-loss benefits, while others share stories of severe side effects. This has fueled debates about the drug’s safety and the need for better warnings.
What’s Next for Ozempic Lawsuits?
The Ozempic lawsuits are still in early stages. Pretrial proceedings in the MDL are focusing on “general causation”—proving that Ozempic can cause the alleged injuries. This phase could take months or even years.
By July 2025, fact discovery on the main issues is expected to be completed. This will help determine whether the lawsuits move forward to trial or settlement discussions. For now, no class-action lawsuit exists, only the MDL for consolidated cases.
How to Stay Informed
Keeping up with the Ozempic lawsuit latest news can be challenging. New developments emerge regularly as more patients come forward. Here are some ways to stay updated:
- Check reputable news sources like Reuters or CBS News for updates.
- Follow legal websites like Lawsuit Legal News for detailed case information.
- Consult an attorney if you’re considering joining the litigation.
Staying informed helps you understand your rights and options if you’ve been affected by Ozempic.
Impact on Patients and Healthcare
The lawsuits have raised awareness about Ozempic’s potential risks. Many patients are now more cautious about using GLP-1 drugs. Doctors are also reevaluating how they prescribe these medications, emphasizing the need for clear risk communication.
Some patients have turned to alternatives, like dietary changes or other medications, to avoid potential side effects. The lawsuits may also push for stronger FDA warnings on Ozempic’s labeling.
Summary
The Ozempic lawsuit latest news reflects a growing legal battle against Novo Nordisk. Patients are suing over severe side effects like gastroparesis, vision loss, and bowel obstructions, claiming inadequate warnings.
The MDL in Pennsylvania is handling over 100 cases, but settlements are likely years away. Novo Nordisk defends Ozempic’s safety, while media and public interest continue to rise.
If you’ve experienced side effects, consulting an attorney could help you explore your legal options.
FAQ
What are the main reasons for Ozempic lawsuits?
Patients are suing due to severe side effects like gastroparesis, vision loss (NAION), and bowel obstructions. They claim Novo Nordisk failed to warn about these risks. Many seek compensation for medical costs and suffering.
Who can file an Ozempic lawsuit?
You may qualify if you experienced serious side effects like stomach paralysis or vision loss after taking Ozempic. Medical documentation and timely filing within your state’s statute of limitations are required. Consult an attorney to evaluate your case.
Are there any settlements in Ozempic lawsuits yet?
No major settlements have been reported as of June 2025. The MDL is in pretrial stages, focusing on causation. Settlements could take years to materialize.
Is vision loss a common side effect of Ozempic?
Vision loss, specifically NAION, is rare but has been linked to Ozempic in some studies. Novo Nordisk denies it’s a recognized side effect. Patients with vision changes should consult their doctor immediately.
Where can I find updates on Ozempic lawsuits?
Check trusted news outlets like Reuters or legal websites like Lawsuit Legal News. Following law firms handling these cases can also provide updates. X posts may offer insights but should be verified for accuracy.